Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2025KY929 | Other Identifier | The Medical and Health Research Project of Zhejiang Province |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to learn if modified diagnosis and treatment (MDT) of neonatal hemolysis (a common cause to newborn jaundice) incorporated with ETCOc measurement (a non-invasive measurement of exhaled gas) works to prevent brain damage in newborns with severe hyperbilirubinemia (sNH). It will also learn about the. occurrence of cranial MRI in the study participants. The main questions it aims to answer are:
Participants will:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| study | Experimental | modified diagnosis and treatment (MDT) for neonatal hemolysis |
|
| control | Other | Control (current) method for sNH (severe neonatal hemolysis) with the description as follow:
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MDT | Combination Product | (actually not combination product, but have to select that option in order to delete warning in "study desine")MDT method for sNH with the description as follow: 1. diagnosis of neonatal hemolysis: The neonatal subjects with symptom of hyperbilirubinemia are diagnosed as hemolysis if they met one criterion from Category A or two criteria from Category B: Category A:
Category B:
(1) TSB ≥ the current ET threshold; (2) TSB > (ET - 2) mg/dL or the increase of TSB > 0.5 mg/dL/h, accompanied by abnormal aEEG findings; (3) TSB > (ET - 2) mg/dL or > 0.5 mg/dL/h, accompanied by a BIND score of 4-6; (4) Presence of clinical manifestations of acute ABE; (5) BIND score of 7-9. |
| Measure | Description | Time Frame |
|---|---|---|
| neural damage confirmed by professional assessments such as Bayley Scales | Neurological impairment, including any of the following: diagnosis of cerebral palsy, diagnostic hearing tests indicating hearing impairment, or a score lower than 85 on the Bayley Scales Neurobehavioral Assessment. Bayley Scales means Bayley Scales of Infant and Toddler Development and it can assess the neural development of infants including Cognitive, Language (Receptive/Expressive), Motor (Fine/Gross), Social-Emotional, and Adaptive Behavior. Standard scores for each domain range from 40 to 160 (mean = 100; SD = 15). Higher scores indicate better developmental outcomes, while lower scores suggest potential delays. For example, a cognitive score of 115 reflects performance above the average range, whereas a score of 85 falls below the average range. | at the age of 12 months |
Not provided
Not provided
Inclusion Criteria: Inclusion Criteria:
Infants with gestational age of 35(+0) to 41(+6) weeks and birth weight ≥ 2500 grams
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| YIngying B | Contact | 086-13777834165 | yingyingbao@zju.edu.cn |
| Name | Affiliation | Role |
|---|---|---|
| Yingying Bao, Doctor | Women's Hospital, Zhejiang University School of Medicine | Principal Investigator |
| Bao, Doctor | Women's Hospital, Zhejiang University School of Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Women's Hospital School of Medicine Zhejiang University | Recruiting | Hangzhou | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D051556 | Hyperbilirubinemia, Neonatal |
| ID | Term |
|---|---|
| D007232 | Infant, Newborn, Diseases |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D006932 | Hyperbilirubinemia |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| control (current management) | Other | Control (current) method for sNH (severe neonatal hemolysis) with the description as follow:
|
|
| D013568 | Pathological Conditions, Signs and Symptoms |